References
Roth J., Glick S.M., Yalow S.R., Berson S.A. Secretion of human growth hormone: physiologic and experimental modification. Metabolism 12: 577, 1963.
Stewart P.M., Smith S., Seth J., Stewart S.E., Cole D., Edwards C.R. Normal growth hormone response to the 75 g oral glucose tolerance test measured by immunoradiometric assay. Ann. Clin. Biochem. 26: 205, 1989.
Serri O., Somma M., Comtois R., Rasio E., Beauregard H., Jilvan N., Hardy J. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy. J. Clin. Endocrinol. Metab. 61: 1185, 1985.
Yalow R.S., Goldsmith S.J., Berson S.A. Influence of physiologic fluctuations in plasma growth hormone on glucose tolerance. Diabetes 18: 402, 1969.
Horton E.S., Johnson C., Lebovitz H.E. Carbohydrate metabolism in uremia. Ann. Intern. Med. 68: 63, 1968.
Grecu E.O., Walter R.M., Gold E.M. Paradoxical release of growth hormone during oral glucose tolerance test in patients with abnormal glucose tolerance. Metabolism 32: 134, 1983.
Becker M.D., Cook G.C., Wright A.D. Paradoxical elevation of growth hormone in active chronic hepatitis. Lancet 2: 1035, 1969.
Vinik A., Pimstone B., Buchanan-Lee B. Impairment of hyperglycemic induced growth hormone suppression in hyperthyroidism. J. Clin. Endocrinol. Metab. 28: 1534, 1968.
Pieters G.F.F.M., Smals A.G.H., Kloppenborg P.W.C. Defective suppression of growth hormone suppression after oral glucose loading in adolescence. J. Clin. Endocrinol. Metab. 51: 265, 1980.
Maccario M., Procopio M., Grottoli S., Oleandri S.E., Razzore P., Camanni F., Ghigo E. In obesity the Somatotrope response to either Growth Hormone-Releasing Hormone on Arginine is inhibited by somatostatin or pirenzepine but not glucose. J. Clin. Endocrinol. Metab. 80: 3774, 1995.
Berelowitz M., Ting N.-C., Murray L. Glucopenia-mediated release of somatostatin from incubated rat hypothalamus: monosaccharide specificity and role of glycolytic intermediates. Endocrinology 124: 826, 1989.
Imaki T., Shibasaki T., Masuda A., Hotta M., Yamauchi N., Demura H., Shizume K., Wakabayashi I., Ling N. The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats. Endocrinology 118: 2390, 1986.
Ghigo E., Miola C., Aimaretti G., Valente F., Procopio M., Arvat E., Yin-Zhang W., Camanni F. Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man. Metabolism 41: 1000, 1992.
Hansen A.P. The effect of intravenous glucose infusion on the exercise-induced serum growth hormone rise in normals and juvenile diabetics. Scand. J. Clin. Lab. Invest. 28: 195, 1971.
Mims R.B., Scott C.L., Modebe O.M., Bethune J.E. Prevention of L-dopa-induced growth hormone stimulation by hyperglycemia. J. Clin. Endocrinol. Metab. 37: 660, 1973.
Davies R.R., Turner S., Johnston D.G. Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone releasing factor 1–44 in normal man. Clin. Endocrinol. 21: 477, 1984.
Peñalva A., Burguera B., Casabiell X., Tresguerres J.A., Dieguez C., Casanueva F.F. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin? Neuroendocrinology 49: 551, 1989.
Valcavi R., Zini M., Dieguez C., Portioli I., Scanlon M.F. Effect of oral glucose on the late growth hormone rise and growth hormone responses to GHRH in normal subjects. Clin. Endocrinol. (Oxf.) 32: 539, 1990.
Valcavi R., Zini M., Davoli S., Portioli I. The late growth hormone rise induced by oral glucose is enhanced by cholinergic stimulation with pyridostigmine in normal subjects. Clin. Endocrinol. (Oxf.) 37: 360, 1992.
Tannenbaum G.S. Interrelationship of somatostatin and growth hormone-releasing hormone in the genesis of the rhythmic secretion of growth hormone. Acta Pediatr. Scand. 367 (Suppl.): 76, 1990.
Hall R., Schally A.V., Evered D., Kastin A.J., Mortimer C.H., Tunbridge W.M.G., Besser G.M., Coy D.H., Goldie D.J., McNeilly A.S., Phenekos C., Weightman D. Action of growth hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet 2: 581, 1973.
Valcavi R., Zini M. Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects. Clin. Endocrinol. (Oxf.) 40: 379, 1994.
Valcavi R., Zini M., Volta C., Ghizzoni L., Azzarito C., Bernasconi S., Portioli I. Effects of oral glucose administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH release in children and adults. J. Clin. Endocrinol. Metab. 79: 1152, 1994.
Isaksson O.G., Eden S., Jansson J.O. Mode of action of pituitary growth hormone on target cells. Annu. Rev. Physiol. 47: 483, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Valcavi, R. Oral glucose tolerance test: an inhibitory or a stimulatory input to growth hormone secretion?. J Endocrinol Invest 19, 253–255 (1996). https://doi.org/10.1007/BF03349877
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349877